About Dr Naveen Ravel
Dr. Naveen Ravel is a senior medical oncologist known for his expertise in treating cancers such as breast, gastrointestinal, lymphomas, and haematological malignancies. He offers advanced therapies including chemotherapy, immunotherapy, targeted, and hormonal treatments. Dr. Ravel is widely respected for his patient-centred approach, clinical leadership, and clear communication style. His work is supported by significant academic contributions and research publications. He is also a member of several prestigious oncology societies. With a compassionate manner and a commitment to personalised care, Dr. Ravel has positively impacted countless patients, earning praise for both his medical skill and empathetic guidance.
OPD Schedule Of Dr Naveen Ravel
Consultation Fees Rs. N/A /-
Apollo Cancer Hospital, Chennai
- MBBS
- MD General Medicine
- DM Medical Oncology
- Breast Cancer
- Gastrointestinal Cancers (Gastric, Colorectal, Oesophageal, Pancreatic, Liver/Cholangiocarcinoma)
- Lymphomas (Hodgkin & Non-Hodgkin)
- Haematological Malignancies (e.g., Acute Lymphoblastic Leukaemia, Hairy Cell Leukaemia, Myeloid Sarcoma)
- Head and Neck Cancers
- Genitourinary Cancers (e.g., Renal Cell Carcinoma)
- Bone Cancers (Medical management, e.g., Osteosarcoma adjuvant therapy)
- Lung Cancer
- Skin Cancers (e.g., Malignant Melanoma)
- Medical Oncology
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Hormonal Therapy
- Senior Consultant Medical Oncologist, Apollo Cancer Centre, Chennai (Current)
- Former Professor and Head of Department (HOD), Department of Medical Oncology, Government Stanley Hospital, Chennai
- European Society of Medical Oncology (ESMO)
- Indian Society of Medical and Paediatric Oncology (ISMPU)
- Indian Medical Association (IMA)
- Indian Society of Oncology
- Prognostic Significance of Her2neu in Gastric & Gastroesophageal Junction Carcinoma. International Journal of Scientific Research (2023).
- Clinico pathological features and outcomes of GIST: A five year retrospective data from a tertiary cancer care centre in south India. European Journal of Molecular & Clinical Medicine (2023).
- Myeloid Sarcoma of the Breast- An Unusual Presentation. International Journal of Scientific Research (2023).
- Quality of Life and Psychological Morbidity in Cancer Patients Receiving Anticancer Therapy during the COVID Pandemic: A Cross Sectional Observational Study from a Tertiary Cancer Care Centre in South India. Cancer therapy & Oncology International Journal (2023).
- Wilms tumour in a two day old neonate: A rare and challenging case. Indian Journal of Case Reports (2023).
- ALK-Negative Inflammatory Myofibroblastic Tumour of the Ileum with Liver Metastasis & Paraneoplastic Syndrome- A Diagnostic & Therapeutic Challenge. Journal of Radiology Case Reports (2023).
- Presented paper on NEO – ADJUVANT Chemotherapy in Osteosarcoma – International Musculoskeletal Conference.
- Presented paper on Breast Cancer – Long term survival – ISO Meeting.
Treatment Type | Estimated Cost (INR) | Estimated Cost (USD) |
Chemotherapy (per cycle) | ₹ 30,000 – ₹ 1,50,000+ | $ 500 – $ 700+ |
Immunotherapy (per cycle) | ₹ 1,50,000 – ₹ 4,00,000+ | $ 1,000 – $ 3,000+ |
Targeted Therapy (monthly cost) | ₹ 50,000 – ₹ 2,50,000+ | $ 600 – $ 3,000+ |
- Language Support: Interpreter services for other languages can be arranged by Cancer Rounds team.
- Visa & Travel Assistance: International patients can receive assistance with medical visa applications, travel planning, airport transfers, and accommodation through Cancer Rounds.
- Pre-treatment Virtual Consultations: Online consultations are available, providing a convenient option for international patients to have initial discussions, review reports, and understand treatment possibilities before travelling.
- Patient-Centred Care: Focuses on providing personalised care tailored to individual patient needs. Known for being empathetic, guiding patients and families through complex decisions with clear communication and emotional support.
- Technology & Innovation: Employs advanced cancer carediagnostic tools (like PET, MRI interpretation) and therapies including Chemotherapy, Radiation Therapy (coordination), Immunotherapy, and Targeted Therapy.